Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Proteomics|April 3, 2016
Mass spectrometry insights into a tandem ubiquitin-binding domain hybrid engineered for the selective recognition of unanchored polyubiquitinDaniel Scott, Tom P Garner, Jed Long, et al.AAPS Pharmscitech|April 22, 2009
Development and evaluation of ethyl cellulose-based transdermal films of furosemide for improved in vitro skin permeationDhaval P Patel, Chitral Mallikarjuna Setty, Gaurav N Mistry, et al.Medical Oncology (Northwood, London, England)|December 8, 2004
Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patientsV R Pai, A T Mazumdar, C D Deshmukh, et al.Journal of Clinical Pharmacology|April 29, 2008
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF intervalM Iwamoto, J T Kost, G C Mistry, et al.Biopharmaceutics & Drug Disposition|June 16, 2007
Dose-proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteersArthur Bergman, Goutam C Mistry, Wen-Lin Luo, et al.Journal of Clinical Pharmacology|August 4, 2010
Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participantsElizabeth M Migoya, Goutam C Mistry, Julie A Stone, et al.American Journal of Physiology. Renal Physiology|January 17, 2019
Zinc deficiency induces hypertension by promoting renal Na<sup>+</sup> reabsorptionClintoria R Williams, Monisha Mistry, Aswathy M Cheriyan, et al.The Pediatric Infectious Disease Journal|June 24, 2010
Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescentsSusan M Abdel-Rahman, Gregory L Kearns, Santiago Topelberg, et al.The British Journal of Dermatology|October 23, 2021
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre studyR Oliver, J G Krueger, S Glatt, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2008
Atazanavir modestly increases plasma levels of raltegravir in healthy subjectsMarian Iwamoto, Larissa A Wenning, Goutam C Mistry, et al.Pageof 9